News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
730,628 Results
Type
Article (41354)
Company Profile (265)
Press Release (688993)
Multimedia
Podcasts (91)
Webinars (20)
Section
Business (204839)
Career Advice (2032)
Deals (35585)
Drug Delivery (128)
Drug Development (81522)
Employer Resources (173)
FDA (16508)
Job Trends (14982)
News (346823)
Policy (32750)
Tag
2027 BioCapital Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (2595)
Accelerated approval (47)
Adcomms (26)
Allergies (171)
Alliances (49580)
ALS (210)
Alzheimer's disease (1793)
Antibody-drug conjugate (ADC) (442)
Approvals (16885)
Artificial intelligence (657)
Autoimmune disease (290)
Automation (56)
Bankruptcy (362)
Best Places to Work (11636)
BIOSECURE Act (20)
Biosimilars (220)
Biotechnology (175)
Bladder cancer (188)
Brain cancer (71)
Breast cancer (747)
Cancer (5788)
Cardiovascular disease (467)
Career advice (1724)
Career pathing (42)
CAR-T (331)
CDC (56)
Celiac Disease (3)
Cell therapy (896)
Cervical cancer (47)
Clinical research (70792)
Collaboration (2046)
Company closure (5)
Compensation (1388)
Complete response letters (79)
COVID-19 (2741)
CRISPR (107)
C-suite (1113)
Cystic fibrosis (152)
Data (7842)
Decentralized trials (3)
Denatured (27)
Depression (161)
Dermatology (86)
Diabetes (586)
Diagnostics (6925)
Digital health (54)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (316)
Drug pricing (200)
Drug shortages (31)
Duchenne muscular dystrophy (283)
Earnings (92063)
Editorial (66)
Employer branding (21)
Employer resources (152)
Events (119460)
Executive appointments (1077)
FDA (20214)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (16)
Frontotemporal dementia (34)
Funding (1716)
Gene editing (233)
Generative AI (56)
Gene therapy (719)
GLP-1 (1052)
Government (4729)
Grass and pollen (6)
Guidances (408)
Healthcare (18994)
HIV (79)
Huntington's disease (56)
IgA nephropathy (97)
Immunology and inflammation (287)
Immuno-oncology (92)
Indications (191)
Infectious disease (3078)
Inflammatory bowel disease (216)
Inflation Reduction Act (14)
Influenza (136)
Intellectual property (288)
Interviews (319)
IPO (16668)
IRA (50)
Job creations (3648)
Job search strategy (1430)
JPM (58)
Kidney cancer (19)
Labor market (99)
Layoffs (562)
Leadership (39)
Legal (7953)
Liver cancer (99)
Longevity (32)
Lung cancer (760)
Lymphoma (429)
Machine learning (60)
Management (59)
Manufacturing (1043)
MASH (185)
Medical device (13926)
Medtech (14047)
Mergers & acquisitions (20159)
Metabolic disorders (1493)
mRNA (204)
Multiple sclerosis (187)
NASH (17)
Neurodegenerative disease (412)
Neuropsychiatric disorders (105)
Neuroscience (3294)
Neurotech (1)
NextGen: Class of 2026 (6521)
Non-profit (4530)
Now hiring (78)
Obesity (698)
Opinion (286)
Ovarian cancer (218)
Pain (252)
Pancreatic cancer (299)
Parkinson's disease (358)
Partnered (33)
Patents (592)
Patient recruitment (667)
Peanut (62)
People (59562)
Pharmaceutical (59)
Pharmacy benefit managers (32)
Phase 1 (22068)
Phase 2 (31192)
Phase 3 (23211)
Pipeline (8667)
Policy (314)
Postmarket research (2568)
Preclinical (9405)
Press Release (64)
Prostate cancer (299)
Psychedelics (54)
Radiopharmaceuticals (320)
Rare diseases (1070)
Real estate (5969)
Recruiting (70)
Regulatory (25374)
Reports (56)
Research institute (2412)
Resumes & cover letters (353)
Rett syndrome (39)
RNA editing (21)
RSV (88)
Schizophrenia (176)
Series A (288)
Series B (213)
Service/supplier (11)
Sickle cell disease (112)
Special edition (23)
Spinal muscular atrophy (166)
Sponsored (48)
Startups (3639)
State (2)
Stomach cancer (18)
Supply chain (126)
Tariffs (87)
The Weekly (62)
Vaccines (1088)
Venture capital (107)
Weight loss (450)
Women's health (125)
Worklife (20)
Date
Today (131)
Last 7 days (842)
Last 30 days (3548)
Last 365 days (30124)
2026 (12363)
2025 (30170)
2024 (35212)
2023 (40073)
2022 (51175)
2021 (55707)
2020 (54081)
2019 (46538)
2018 (35020)
2017 (32111)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29264)
2010 (27328)
Location
Africa (741)
Alabama (93)
Alaska (7)
Arizona (348)
Arkansas (14)
Asia (39662)
Australia (6503)
California (13240)
Canada (3759)
China (1333)
Colorado (566)
Connecticut (574)
Delaware (403)
Europe (85824)
Florida (1980)
Georgia (424)
Hawaii (3)
Idaho (62)
Illinois (1050)
India (90)
Indiana (599)
Iowa (23)
Japan (534)
Kansas (131)
Kentucky (50)
Louisiana (40)
Maine (76)
Maryland (1585)
Massachusetts (9434)
Michigan (362)
Minnesota (715)
Mississippi (6)
Missouri (144)
Montana (33)
Nebraska (29)
Nevada (142)
New Hampshire (84)
New Jersey (3479)
New Mexico (29)
New York (3457)
North Carolina (1678)
North Dakota (9)
Northern California (6640)
Ohio (396)
Oklahoma (23)
Oregon (41)
Pennsylvania (2661)
Puerto Rico (29)
Rhode Island (50)
South America (1112)
South Carolina (85)
South Dakota (2)
Southern California (5219)
Tennessee (210)
Texas (2099)
United States (46663)
Utah (393)
Vermont (1)
Virginia (321)
Washington D.C. (80)
Washington State (1056)
West Virginia (4)
Wisconsin (125)
Wyoming (2)
730,628 Results for "veru inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Veru to Report Fiscal 2026 Second Quarter Financial Results on May 13th
May 6, 2026
·
10 min read
Press Releases
Veru Reports Fiscal 2026 Second Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress
May 13, 2026
·
15 min read
Press Releases
Veru to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
February 19, 2026
·
8 min read
Press Releases
Veru Reports Fiscal 2026 First Quarter Financial Results and Clinical Program Progress
February 11, 2026
·
17 min read
Press Releases
Veru to Report Fiscal 2026 First Quarter Financial Results on February 11th
February 5, 2026
·
8 min read
Press Releases
Veru Enrolls First Patient in Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss
March 9, 2026
·
12 min read
Press Releases
Veru to Present Two Abstracts at ObesityWeek 2025
October 31, 2025
·
10 min read
Weight loss
Veru’s Drug Spares Lean Mass in Overweight, Obese Adults on Wegovy—Is It Enough?
Patients taking Novo Nordisk’s Wegovy plus Veru’s enobosarm saw 71% lower lean mass loss than those who were taking Wegovy alone but investors await more data.
January 27, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Veru Announces Pricing of $25 Million Public Offering
October 31, 2025
·
5 min read
Press Releases
Veru to Report Fiscal Year 2025 Financial Results on December 17th
December 11, 2025
·
10 min read
1 of 73,063
Next
